50 Participants Needed

Elasticity Imaging for Breast Cancer

NS
EK
YL
Overseen ByYangpei Liu, MSc
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: Columbia University
Stay on Your Current MedsYou can continue your current medications while participating
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

For this study, the investigators propose investigation of a new imaging technique, Harmonic Motion Imaging (HMI), and the evaluation of its potential role in prediction of breast cancer response to neoadjuvant chemotherapy (NACT). The investigators hypothesize that changes in HMI parameters will predict response to neoadjuvant systemic therapy in early-stage breast cancer.

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment Harmonic Motion Imaging for breast cancer?

Research shows that Harmonic Motion Imaging (HMI) can help differentiate between benign and malignant breast tumors by measuring how much the tissue moves when sound waves are applied. Malignant tumors tend to move less than benign ones, which can help doctors identify cancerous tissue without needing a biopsy.12345

Is elasticity imaging for breast cancer safe for humans?

The research on harmonic motion imaging (HMI) for breast cancer suggests it is a non-invasive technique that uses sound waves to assess tissue stiffness, and it has been tested in human subjects without reported safety issues. Additionally, ultrasound elastography, a related technique, is widely used and considered safe for evaluating tissue properties in various conditions.13678

How does elasticity imaging differ from other breast cancer treatments?

Elasticity imaging is unique because it uses ultrasound to assess the stiffness of breast tissue, helping to differentiate between benign and malignant tumors without invasive procedures. This technique provides a non-invasive way to evaluate the mechanical properties of breast tissue, potentially reducing the need for unnecessary biopsies.125910

Research Team

EK

Elisa Konofagou, PhD

Principal Investigator

Columbia University

Eligibility Criteria

This trial is for women aged 18 or older with invasive breast cancer of at least 4 mm in size, who are eligible for neoadjuvant systemic therapy. It's not suitable for pregnant or breastfeeding women, those with breast implants, or a history of laser/radiation therapy to the affected breast.

Inclusion Criteria

Women who are 18 years old or older.
Your doctor thinks you should get medicine before surgery, and they will decide the right amount and timing for you.
You have invasive breast cancer, and the size of the main tumor in the breast is at least 4 millimeters.

Exclusion Criteria

Patient is pregnant or lactating
You have breast implants.
You have had laser or radiation therapy on the affected breast in the past.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive neoadjuvant chemotherapy and undergo Harmonic Motion Imaging (HMI) to predict response

28 weeks
Regular visits for chemotherapy and imaging assessments

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Harmonic motion imaging
Trial Overview The study is testing Harmonic Motion Imaging (HMI), a new imaging technique designed to predict how early-stage breast cancer responds to chemotherapy given before surgery (neoadjuvant chemotherapy).
Participant Groups
1Treatment groups
Experimental Treatment
Group I: HMI GroupExperimental Treatment1 Intervention
Women undergoing standard neoadjuvant chemotherapy for breast cancer

Find a Clinic Near You

Who Is Running the Clinical Trial?

Columbia University

Lead Sponsor

Trials
1,529
Recruited
2,832,000+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+

Findings from Research

Harmonic motion imaging (HMI) effectively differentiates between benign and malignant breast tumors by measuring their stiffness and displacement, with malignant tumors showing lower displacement (1.1 µm) compared to benign tumors (3.6 µm) and surrounding tissue (6.4 µm).
The study involved 10 female subjects and demonstrated a strong correlation between in vivo HMI results and post-surgical ex vivo findings, suggesting that HMI could enhance diagnostic accuracy in clinical settings when used alongside traditional imaging methods.
Harmonic motion imaging of human breast masses: an in vivo clinical feasibility.Saharkhiz, N., Ha, R., Taback, B., et al.[2022]
The real-time elasticity imaging (EI) ultrasound system demonstrated a sensitivity of 100% and specificity of 95% in distinguishing between benign and malignant breast lesions in a study of 208 patients with 251 lesions.
This technique could significantly reduce unnecessary breast biopsies by accurately identifying benign lesions, as it correctly classified 187 out of 197 benign lesions based on the EI/B-mode ratio.
Real-time ultrasound elasticity of the breast: initial clinical results.Barr, RG.[2019]
Using elevated mechanical index (MI) values in harmonic imaging techniques for hepatic shear wave elasticity imaging significantly improved the yield of shear wave speed measurements by 27% at a depth of 5 cm, especially in challenging cases.
High-MI tracking enhanced the quality of imaging data by increasing the signal-to-noise ratio and reducing motion jitter, indicating a clinical benefit in using higher acoustic output for better diagnostic results.
Evaluating the Benefit of Elevated Acoustic Output in Harmonic Motion Estimation in Ultrasonic Shear Wave Elasticity Imaging.Deng, Y., Palmeri, ML., Rouze, NC., et al.[2019]

References

Harmonic motion imaging of human breast masses: an in vivo clinical feasibility. [2022]
Real-time ultrasound elasticity of the breast: initial clinical results. [2019]
Evaluating the Benefit of Elevated Acoustic Output in Harmonic Motion Estimation in Ultrasonic Shear Wave Elasticity Imaging. [2019]
Real-time sonoelastography - a new application in the field of liver disease. [2016]
A Force-Matched Approach to Large-Strain Nonlinearity in Elasticity Imaging for Breast Lesion Characterization. [2023]
An analytical model of full-field displacement and strain induced by amplitude-modulated focused ultrasound in harmonic motion imaging. [2022]
WFUMB guidelines and recommendations for clinical use of ultrasound elastography: Part 1: basic principles and terminology. [2022]
Improvement of Shear Wave Motion Detection Using Harmonic Imaging in Healthy Human Liver. [2018]
What challenges must be overcome before ultrasound elasticity imaging is ready for the clinic? [2021]
10.United Statespubmed.ncbi.nlm.nih.gov
AAPM/RSNA physics tutorial for residents: topics in US: beyond the basics: elasticity imaging with US. [2016]